Concepedia

Therapeutic Interchange

Therapeutic Interchange is a formulary management practice whereby an authorized prescriber or pharmacist substitutes a patient’s originally prescribed drug with a chemically different agent from the same therapeutic class, selected under evidence-based protocols to provide a substantially equivalent therapeutic effect—often at lower cost—and thereby distinguished from generic substitution between pharmaceutically equivalent products.

74

Publications

1.8K

Citations

309

Authors

188

Institutions

Publications per year

2017–2026

19

Variants

Therapeutic Substitution

Parents

Children

Publications

74

The nocebo effect challenges the non-medical infliximab switch in practice

Niels Boone, L. Liu, Mariëlle Romberg‐Camps et al. · European Journal of Clinical Pharmacology · 2018 · 116 citations · Full text

, , +17

Are all angiotensin-converting enzyme inhibitors interchangeable?

Curt D. Furberg, Bertram Pitt · Journal of the American College of Cardiology · 2001 · 83 citations

, , +7

Generic Products of Antiepileptic Drugs (AEDs): Is It an Issue?

Meir Bialer · Epilepsia · 2007 · 80 citations · Full text

, , +17

Biosimilars: Policy, clinical, and regulatory considerations

Scott Gottlieb · American Journal of Health-System Pharmacy · 2008 · 57 citations

, , +17

Generic Antiepileptic Drugs: Current Controversies and Future Directions

Michael Privitera · Epiliepsy currents/Epilepsy currents · 2008 · 51 citations · Full text

, , +17

1–5 of 74

Authors

309

  1. LE
    László Endrényi

    University of Toronto, Canada

    3 publications · 77 citations

    3

    h-index

  2. SC
    Shein‐Chung Chow

    Duke University, United States

    3 publications · 68 citations

    3

    h-index

  3. NV
    Norman V. Carroll

    Virginia Commonwealth University, United States

    3 publications · 47 citations

    3

    h-index

  4. LT
    László Tóthfalusi

    Semmelweis University, Hungary

    2 publications · 64 citations

    2

    h-index

  5. MC
    Mei‐Ling Chen

    University of British Columbia, Canada

    2 publications · 43 citations

    2

    h-index

1–5 of 309

Institutions

188

  1. Duke University

    Durham, United States

    5 h-index

    5 publications

    123 citations

  2. University of Toronto

    Toronto, Canada

    4 h-index

    4 publications

    114 citations

  3. Health Canada

    Ottawa, Canada

    4 h-index

    6 publications

    114 citations

  4. Universitat Autònoma de Barcelona

    Cerdanyola del Vallès, Spain

    3 h-index

    3 publications

    45 citations

  5. Semmelweis University

    Budapest, Hungary

    3 h-index

    3 publications

    77 citations

  6. Virginia Commonwealth University Medical Center

    Richmond, United States

    3 h-index

    3 publications

    47 citations

  7. Pharmo Institute

    Utrecht, Netherlands

    3 h-index

    4 publications

    65 citations

  8. United States Food and Drug Administration

    Silver Spring, United States

    3 h-index

    7 publications

    164 citations

1–8 of 188

Venues

  1. American Journal of Health-System Pharmacy

    AJHP · 10 publications · 222 citations

    10

    h-index

  2. PubMed

    Repository · 5 publications · 127 citations

    5

    h-index

  3. Generics and Biosimilars Initiative Journal

    4 publications · 85 citations

    4

    h-index

  4. Clinical Pharmacology & Therapeutics

    CPT · 3 publications · 34 citations

    3

    h-index

  5. Statistics in Medicine

    2 publications · 38 citations

    2

    h-index

1–5